000 03065nam a22003855i 4500
001 82244
003 ES-MaUEC
005 20230207040403.0
007 cr nn 008mamaa
008 141211s2015 gw | s |||| 0|eng d
020 _a9783319126791
024 7 _a10.1007/978-3-319-12679-1
_2doi
050 4 _aRC523
_b2015 EB
100 1 _aBraak, Heiko
_0Local
_995045
245 1 0 _aNeuroanatomy and Pathology of Sporadic Alzheimer's Disease
_cby Heiko Braak, Kelly Del Tredici.
260 _aCham, Switzerland
_bSpringer
_c2015
300 _a1 recurso en línea (XI, 162 páginas)
_b48 ilustraciones, 44 ilustraciones en color
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
490 0 _aAdvances in Anatomy, Embryology and Cell Biology
_x0301-5556
_v215
505 0 _aPrologue -- General Morphology of Alzheimer-associated intraneuronal pathology -- Consistent and systematic changes in the distribution pattern of intraneuronal inclusions render staging possible -- Basic organization of involved structures -- Presymptomatic stages -- General morphology of Alzheimer-associated extracellular pathology -- Symptomatic stages -- The progression of cortical lesions mimics the pattern of myelination in reverse order -- Tauopathies -- CSF biomarkers and imaging techniques -- The staging hypothesis: assumptions, challenges, potential -- Technical considerations.Â{u2802}Â{uE000}
520 3 _aAs indicated by its title, this monograph deals chiefly with morphologically recognizable deviations from the normal anatomical condition of the human CNS. The AD-associated pathology is illustrated from its beginnings (sometimes even in childhood) to its final form, which is reached late in life. The AD process commences much earlier than the clinically recognizable phase of the disorder, and its timeline includes an extended preclinical phase. The further the pendulum swings away from the symptomatic final stages towards the early pathology, the more obvious the lesions become, although from a standpoint of severity they are more unremarkable and thus frequently overlooked during routine neuropathological assessment. For this reason, the authors deal with the hallmark lesions in the early phases of the AD process in considerable detail.
710 2 _aSpringerLink (Online service)
_0Local
_9106996
942 _2lcc
_cLE
650 0 _9140743
_aGeriatría
_0
650 7 _aPatología
_0
_2embne
_9138489
650 7 _aNeurociencias
_0
_2embne
_9158907
700 1 _aDel Tredici, Kelly.
_995046
_0Local
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-3-319-12679-1
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
907 _a.b12908848
_b10-10-17
_c10-02-16
988 _aSpringer_Medicine_2015
998 _am
_a_alco
_a_vill
_b - -
_cm
_dz
_e-
_feng
_ggw
_h0
945 _aRC523 .B733 2015 EB
_g1
_ieBOOK
_j0
_lmae
_o-
_pEUR0.00
_q-
_r-
_sb
_t15
_u0
_v0
_w0
_x0
_y.i11576522
_z06-04-17
999 _c82244
_d82244
_x1